×
About 78 results

ALLMedicine™ Aids-related Lymphomas Center

Research & Reviews  28 results

Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
https://clinicaltrials.gov/ct2/show/NCT02911142

Oct 5th, 2022 - Background Kaposi sarcoma herpesvirus (KSHV)-associated primary effusion lymphoma (PEL) is an aggressive B cell neoplasm with clinicopathologic and molecular profiles distinct from other AIDS-related lymphomas. There are no prospective studies on ...

Midkine inhibitor (iMDK) induces apoptosis of primary effusion lymphoma via G2/M cell c...
https://doi.org/10.1016/j.leukres.2022.106826
Leukemia Research; Ueno M, Kariya R et. al.

Mar 23rd, 2022 - Primary effusion lymphoma (PEL) is an aggressive B-cell non-Hodgkin lymphoma in immunocompromised individuals such as AIDS patients. PEL shows a poor prognosis (median survival time < 6 months) compared with other AIDS-related lymphomas, and is ge...

Survival of HIV-infected patients with high-grade non-Hodgkin's lymphomas: A retrospect...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498086
PloS One; Manyau MCP, Mudzviti T et. al.

Sep 18th, 2020 - Rituximab in combination with chemotherapy is now widely accepted as standard of care for AIDS-related lymphomas (ARLs) of B-cell origin. However, the clinical impact of rituximab in resource limited settings remains unknown. Different settings an...

AIDS-related lymphomas: Treatment of systemic lymphoma
https://www.uptodate.com//contents/aids-related-lymphomas-treatment-of-systemic-lymphoma
Lawrence D Kaplan

INTRODUCTION Human immunodeficiency virus (HIV) infection results in impaired cellular immunity, a condition known to predispose persons to develop neoplasms. As the lifespan of HIV-infected patients has increased, malignancies have become a known...

Treatment and prognosis of primary central nervous system lymphoma
https://www.uptodate.com//contents/treatment-and-prognosis-of-primary-central-nervous-system-lymphoma
Tracy Batchelor

INTRODUCTION Primary central nervous system lymphoma (PCNSL) is an uncommon variant of extranodal non-Hodgkin lymphoma (NHL) that involves the brain, leptomeninges, eyes, or spinal cord without evidence of systemic disease. The treatment, complica...

see more →

Clinicaltrials.gov  3 results

Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
https://clinicaltrials.gov/ct2/show/NCT02911142

Oct 5th, 2022 - Background Kaposi sarcoma herpesvirus (KSHV)-associated primary effusion lymphoma (PEL) is an aggressive B cell neoplasm with clinicopathologic and molecular profiles distinct from other AIDS-related lymphomas. There are no prospective studies on ...

Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
https://clinicaltrials.gov/ct2/show/NCT02228512

Aug 31st, 2018 - Background: Kaposi sarcoma herpesvirus (KSHV)-associated primary effusion lymphoma (PEL) and large cell lymphoma arising from KSHV-MCD are aggressive B cell neoplasms with clinicopathologic and molecular profiles distinct from other AIDS-related l...

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma
https://clinicaltrials.gov/ct2/show/NCT00126243

Aug 17th, 2005 - HIV infection is associated with a high incidence of AIDS-related lymphomas (ARL). Since the use of highly active antiretroviral therapy (HAART), the incidence of AIDS-defining illnesses has decreased, leading to a significant improvement in survi...

see more →